KR20060092308A - Method for producing guinarine by tissue culture of poppy family - Google Patents
Method for producing guinarine by tissue culture of poppy family Download PDFInfo
- Publication number
- KR20060092308A KR20060092308A KR1020050012957A KR20050012957A KR20060092308A KR 20060092308 A KR20060092308 A KR 20060092308A KR 1020050012957 A KR1020050012957 A KR 1020050012957A KR 20050012957 A KR20050012957 A KR 20050012957A KR 20060092308 A KR20060092308 A KR 20060092308A
- Authority
- KR
- South Korea
- Prior art keywords
- raw
- guinealine
- liquid
- production
- fresh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241000218180 Papaveraceae Species 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title abstract description 40
- 241000196324 Embryophyta Species 0.000 claims abstract description 27
- 238000004113 cell culture Methods 0.000 claims abstract description 19
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- 239000003960 organic solvent Substances 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 16
- 238000000605 extraction Methods 0.000 claims abstract description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 36
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
- 235000002639 sodium chloride Nutrition 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 24
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 20
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 19
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 18
- 229940041514 candida albicans extract Drugs 0.000 claims description 16
- 239000012138 yeast extract Substances 0.000 claims description 16
- 241000123650 Botrytis cinerea Species 0.000 claims description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 12
- 239000004310 lactic acid Substances 0.000 claims description 9
- 235000014655 lactic acid Nutrition 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 238000004114 suspension culture Methods 0.000 claims description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical group [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 8
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 8
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 229920002101 Chitin Polymers 0.000 claims description 5
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 229920001503 Glucan Polymers 0.000 claims description 5
- 241000233624 Phytophthora megasperma Species 0.000 claims description 5
- 244000001385 Sanguinaria canadensis Species 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 241001233914 Chelidonium majus Species 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- 235000011148 calcium chloride Nutrition 0.000 claims description 4
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 4
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 4
- 239000004323 potassium nitrate Substances 0.000 claims description 4
- 235000010333 potassium nitrate Nutrition 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 claims description 3
- 229940064399 botrytis cinerea extract Drugs 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 claims 2
- 235000001258 Cinchona calisaya Nutrition 0.000 claims 1
- 241001412143 Eriogonum corymbosum Species 0.000 claims 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 claims 1
- 229960000948 quinine Drugs 0.000 claims 1
- 239000002609 medium Substances 0.000 abstract description 24
- 238000011084 recovery Methods 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 12
- 230000001965 increasing effect Effects 0.000 abstract description 10
- 239000000203 mixture Substances 0.000 abstract description 7
- 240000001090 Papaver somniferum Species 0.000 abstract description 6
- 150000007524 organic acids Chemical class 0.000 abstract description 6
- 239000006143 cell culture medium Substances 0.000 abstract description 5
- 235000005985 organic acids Nutrition 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 235000013373 food additive Nutrition 0.000 abstract description 3
- 239000002778 food additive Substances 0.000 abstract description 3
- 230000008635 plant growth Effects 0.000 abstract description 3
- 239000000460 chlorine Substances 0.000 abstract description 2
- 229910052801 chlorine Inorganic materials 0.000 abstract description 2
- 125000001309 chloro group Chemical group Cl* 0.000 abstract description 2
- 238000007796 conventional method Methods 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000000052 vinegar Substances 0.000 abstract description 2
- 235000021419 vinegar Nutrition 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- 230000012010 growth Effects 0.000 description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 239000010931 gold Substances 0.000 description 6
- 229910052737 gold Inorganic materials 0.000 description 6
- -1 guinealine Chemical compound 0.000 description 6
- 239000003630 growth substance Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000006870 ms-medium Substances 0.000 description 5
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 4
- 241000700198 Cavia Species 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- XMLSXPIVAXONDL-UHFFFAOYSA-N trans-jasmone Natural products CCC=CCC1=C(C)CCC1=O XMLSXPIVAXONDL-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XMLSXPIVAXONDL-PLNGDYQASA-N Jasmone Chemical compound CC\C=C/CC1=C(C)CCC1=O XMLSXPIVAXONDL-PLNGDYQASA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- IVLCENBZDYVJPA-ARJAWSKDSA-N cis-Jasmone Natural products C\C=C/CC1=C(C)CCC1=O IVLCENBZDYVJPA-ARJAWSKDSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012364 cultivation method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 239000006194 liquid suspension Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000005648 plant growth regulator Substances 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WEEFNMFMNMASJY-UHFFFAOYSA-M 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium;chloride Chemical compound [Cl-].C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 WEEFNMFMNMASJY-UHFFFAOYSA-M 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LLEJIEBFSOEYIV-UHFFFAOYSA-N Chelerythrine Natural products C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 LLEJIEBFSOEYIV-UHFFFAOYSA-N 0.000 description 1
- LZJHNXHYKRKCDZ-UHFFFAOYSA-N Chelilutine Chemical compound C1=C2OCOC2=CC2=CC=C3C4=C(OC)C=C(OC)C(OC)=C4C=[N+](C)C3=C21 LZJHNXHYKRKCDZ-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- RATMHCJTVBHJSU-UHFFFAOYSA-N Dihydrochelerythrine Natural products C1=C2OCOC2=CC2=C(N(C)C(O)C=3C4=CC=C(C=3OC)OC)C4=CC=C21 RATMHCJTVBHJSU-UHFFFAOYSA-N 0.000 description 1
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 241000219098 Parthenocissus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- QXVJDCUNQFSDBQ-UHFFFAOYSA-N Sanguilutine Chemical compound C1=C(OC)C(OC)=C2C=[N+](C)C3=C(C=C(C(OC)=C4)OC)C4=CC=C3C2=C1OC QXVJDCUNQFSDBQ-UHFFFAOYSA-N 0.000 description 1
- YDJJXMQEUMHAEG-UHFFFAOYSA-N Sanguilutine Natural products O(C)c1c(OC)cc(OC)c2-c3c([N+](C)[C-]c12)c1c(cc(OC)c(OC)c1)cc3 YDJJXMQEUMHAEG-UHFFFAOYSA-N 0.000 description 1
- FUAPOWMHFINSMM-UHFFFAOYSA-N Sanguirubine Chemical compound C1=C2OCOC2=C2C=[N+](C)C3=C(C=C(C(OC)=C4)OC)C4=CC=C3C2=C1OC FUAPOWMHFINSMM-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229930015421 benzophenanthridine alkaloid Natural products 0.000 description 1
- 150000008622 benzophenanthridines Chemical class 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- DKQVJMREABFYNT-UHFFFAOYSA-N ethene Chemical compound C=C.C=C DKQVJMREABFYNT-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 229940084560 sanguinarine Drugs 0.000 description 1
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 생귀나린의 제조방법에 관한 것으로, 더욱 상세하게는, 생귀나린을 고함량으로 함유하는 양귀비과 식물을 조직 배양하여 생귀나린을 제조하는 데 있어, 식물의 성장 및 생귀나린의 생산을 위한 배지의 조성을 달리하고 엘리씨터를 첨가하여 생귀나린의 생산량을 증대시키며, 이로부터 얻어진 생귀나린을 포함하는 식물세포 배양액을 건조한 후, 유기산과 유기용매를 이용하여 생귀나린 추출액을 만들고, 염을 첨가하여 식물세포 배양액으로부터 생귀나린을 효율적으로 분리함으로써, 생귀나린의 생산성 및 회수율을 모두 향상시킬 수 있는 양귀비과 식물의 조직 배양에 의한 생귀나린의 제조방법에 관한 것이다.The present invention relates to a method for producing raw guinarin, and more particularly, in the production of fresh guinealine by tissue culture of a poppy family containing a high content of raw guinealine, a medium for plant growth and production of guinealine To increase the production of guinarine by varying the composition of the chlorine and to increase the amount of guinealine, and to dry the plant cell culture medium containing the guinarine obtained from this, to make a vinegar extract using organic acids and organic solvents, add salt The present invention relates to a method for producing raw guirin by tissue culture of poppy plants, which can improve both productivity and recovery rate of fresh guinealine by efficiently separating the raw guinealine from the plant cell culture solution.
본 발명에 따르면, 종래의 방법에 비하여 생귀나린의 생산성 및 회수율을 현격히 향상시킬 수 있고, 인체에 무해한 추출방법을 이용함으로서 안전성을 높힐 수 있으며, 또한, 항균물질로 광범위한 분야에서 사용되고 있는 생귀나린의 대량 생산을 가능하게 하여, 이를 이용한 화장품, 식품 첨가제 및 의료용 제제의 생산원가를 절감시키는 효과가 있다.According to the present invention, the productivity and recovery rate of raw guinealine can be significantly improved compared to the conventional method, and the safety can be increased by using an extraction method that is harmless to the human body. By enabling mass production, there is an effect of reducing the production cost of cosmetics, food additives and medical preparations using the same.
생귀나린, 엘리씨터, 안전성, 회수율 Raw curiosity, element, safety, recovery
Description
도 1의 (가)는 보트리티스 시네레아(Botrytis cinerea)를 엘리시터로 사용한 경우, (나)는 효모 추출물(yeast extract)을 엘리시터로 사용한 경우, (다)는 효모 추출물을 정제하여 사용한 경우 생귀나린 및 다이하이드로 생귀나린의 생산 증가량을 엘리시터를 첨가하지 않은 대조구(control)와 비교하여 나타낸 그래프이다. Figure 1 (a) is used when Botrytis cinerea ( Elysit ) as an eliminator, (b) when the yeast extract (yeast extract) is used as an eliminator, (c) is used to purify the yeast extract In the case of the production of fresh guinarin and dihydro guinarine is a graph showing a comparison with the control (control) without the addition of the eliminator.
도 2는 아세트산, 락틱산, 구연산을 첨가하여 생귀나린을 추출한 경우 추출 효율을 나타낸 그래프이다. Figure 2 is a graph showing the extraction efficiency when the extraction of raw guinarin by adding acetic acid, lactic acid, citric acid.
본 발명은 생귀나린의 제조방법에 관한 것으로, 더욱 상세하게는, 생귀나린을 고함량으로 함유하는 양귀비과 식물을 조직 배양하여 생귀나린을 제조하는 데 있어, 식물의 성장 및 생귀나린의 생산을 위한 배지의 조성을 달리하고 엘리씨터를 첨가하여 생귀나린의 생산량을 증대시키며, 이로부터 얻어진 생귀나린을 포함하는 식물세포 배양액을 건조한 후, 유기산과 유기용매를 이용하여 생귀나린 추출액을 만들고, 염을 첨가하여 식물세포 배양액으로부터 생귀나린을 효율적으로 분리함으로써, 생귀나린의 생산성 및 회수율을 모두 향상시킬 수 있는 양귀비과 식물의 조직 배양에 의한 생귀나린의 제조방법에 관한 것이다.The present invention relates to a method for producing raw guinarin, and more particularly, in the production of fresh guinealine by tissue culture of a poppy family containing a high content of raw guinealine, a medium for plant growth and production of guinealine To increase the production of guinarine by varying the composition of the chlorine and to increase the amount of guinealine, and to dry the plant cell culture medium containing the guinarine obtained from this, to make a vinegar extract using organic acids and organic solvents, add salt The present invention relates to a method for producing raw guirin by tissue culture of poppy plants, which can improve both productivity and recovery rate of fresh guinealine by efficiently separating the raw guinealine from the plant cell culture solution.
생귀나린(sanguinarine)이란 아메리카 대륙에서 생활하던 토속민들이 민간요법제로 사용하던 약제로서, 북미 및 캐나다 등지에 서식하는 양비귀과(Papaveraceae)의 생귀나리아 케나덴시스 린네(Sanguinaria Canadensis Linne) 식물의 근경과 박락희, 백굴채, 애기똥풀 등의 다년생 식물 및 한해살이 풀인 금영화(Eschscholtzia california) 등의 식물에 주로 함유되어 있는 벤조페난트리딘 알칼로이드(benwophenanthridine alkaloids)계 화합물의 일종이다.Sanguinarine is a folk remedy used by indigenous people living in the Americas, and is rooted in the Sanguinaria Canadensis Linne plant of the Papaveraceae in North America and Canada. It is a kind of benzophenanthridine alkaloids-based compound mainly contained in perennial plants such as Park, Rak-hee, Baekchulchae and Celandine, and plants such as Eschscholtzia california .
생귀나린은 세균, 곰팡이류, 효모, 원생동물 등에 광범위한 항생효과 및 항암효과를 나타내는 것으로 알려져 있으며, 특히 치과용 항생제로 널리 이용되고 있다. 생귀나린의 광범위한 항생효과로 인하여, 의약뿐 아니라 화장품 및 식품첨가제로의 응용이 확대되고 있으며, 이에 대한 종래기술로써 미국특허 제4,335,110호, 미국특허 제4,145,412호, 미국특허 제4,689,216호 등을 들 수 있다. Raw Guinarin is known to exhibit a wide range of antibiotic and anticancer effects, such as bacteria, fungi, yeast, protozoa, etc., and is particularly widely used as a dental antibiotic. Due to the broad antibiotic effect of Saint-Ginarin, the application of not only medicine, but also cosmetics and food additives has been expanded, and US Patent No. 4,335,110, US Patent No. 4,145,412, US Patent No. 4,689,216, etc. have.
한편, 생귀나린을 생산하는 방법으로는 합성법, 식물세포 배양법 및 직접 재배법 등을 들 수 있는데, 합성법은 그 단계가 복잡하고 수율이 낮아 산업적으로 대량 생산하기에는 부적절한 방법으로 현재까지 성공예가 보고된 바 없다. 그리고, 직접 재배법은 현재까지 생귀나린을 가장 고함량으로 함유하고 있다고 알려진 양귀비과 식물을 재배하여 이로부터 생귀나린을 수득하는 방법으로, 비교적 간단한 방 법이기는 하나 생귀나린의 함량이 환경적, 지리적 영향을 많이 받기 때문에 생산량이 많지 않다는 단점이 있다. 실질적으로 생귀나린을 상업적으로 생산하고 있는 프랑스의 알반 뮬러사(alban muller international)의 경우, 양귀비과의 피뿌리로부터 얻어지는 생귀나린의 최종 수율이 뿌리 건조 중량의 1% 내외이다. On the other hand, methods for producing raw guinarin include synthetic methods, plant cell culture methods, and direct cultivation methods, which are not suitable for industrial mass production due to its complicated steps and low yield. . In addition, the direct cultivation method is to grow a poppy family known to contain the highest content of raw guinea to date to obtain raw guinea from this, although the relatively simple method, the content of the raw guinarin is environmentally and geographically affected. There is a drawback that the production is not much because it receives a lot. In the case of Alban Muller International, France, which produces commercially fresh raw guinarin, the final yield of raw guinealine from the roots of the poppy family is around 1% of the root dry weight.
상기와 같은 이유로 인해, 최근에는 식물의 세포 배양을 이용하여 생귀나린을 생산하고자 하는 시도가 이루어지고 있다. 식물 세포 배양법은 다른 방법에 의한 생산이 불가능하거나 경제성이 없을 경우 사용되는 방법으로, 생산량을 쉽게 조절할 수 있을뿐만 아니라, 배양기 내에서 자란 세포를 이용하므로 수확 공정이 비교적 간단하다는 장점이 있다. 특히, 국내와 같이 향정신성 의약품과 관련하여 생귀나린을 함유하고 있는 양비귀과 식물의 노지재배가 법적으로 금지되어 있는 국가의 경우, 생귀나린의 생산방법에 있어 식물 세포 배양법이 가장 적절하다고 할 수 있다. For these reasons, in recent years, attempts have been made to produce raw guinealine using plant cell cultures. Plant cell culture is a method used when production by other methods is not possible or economical, as well as easy to control the production, there is an advantage that the harvesting process is relatively simple because it uses the cells grown in the incubator. In particular, in the countries where the cultivation of wild creeper plants containing raw guinea plants in relation to psychotropic drugs is prohibited by law, plant cell culture is the most appropriate method for producing raw guinea pigs.
양귀비과 식물의 세포배양을 통한 생귀나린의 생산과 관련된 종래기술로서, 한국특허출원 제10-1995-12880호는 고함량의 생귀나린을 함유하는 박락희와 멕클레야 마이크로카파 식물의 현탁 세포배양액에 엘리씨터를 첨가하여 생귀나린 및 그 유도체의 생산성을 향상시키는 방법에 관하여 개시하고 있다. 상기 특허는 그 동안 연구가 미비하였던 양비귀과에 속하는 식물 중 멕클레야 속 식물을 사용하였다는 점에서 의의가 있으나, 배양액에 존재하는 유리상태의 생귀나린 및 그 유도체를 인체에 유해한 염산 및 메탄올을 사용한 공지의 방법에 따라 추출함으로써 안전성에 대한 문제가 있고, 회수 가능한 생귀나린 및 그 유도체의 양을 향상시키지 못하 여 최종적인 생귀나린의 생산량을 증대시키지 못하였다는 단점이 있다. As a related art related to the production of raw guinealine through the cell culture of the poppy family, Korean Patent Application No. 10-1995-12880 discloses the elimination of suspended cell culture solution of Park, Rak-hee and Mccleya microkappa plants containing high contents of guinealine. Disclosed is a method of improving the productivity of guinarine and its derivatives by adding a seed. The patent has a meaning in that the plant of the genus McCleya, which has not been studied in the past, has been used, but it is possible to use hydrochloric acid and methanol, which are harmful to the human body, in the free state of guinarine and its derivatives in the culture medium. There is a problem in safety by extraction according to the known method used, there is a disadvantage that it does not improve the amount of recoverable raw guinarin and its derivatives and did not increase the final production of raw guinarine.
또한, 한국특허출원 제10-1994-26350호는 식물세포 배양배지에 사이클로덱스트린을 첨가하여 생귀나린을 비롯한 안트라퀴논, 멘톨 및 택솔 등의 식물세포 배양에 의한 2차 대사물의 생산성을 증가시키는 방법에 관하여 개시하고 있다. 이 또한, 안전성에 대한 문제와, 까다로운 식물세포 배양에 의한 2차 대사물의 추출공정을 개선하지 못하여, 최종적인 생귀나린의 회수율을 향상시키지 못하였다는 문제점이 있다. In addition, Korean Patent Application No. 10-1994-26350 discloses a method for increasing the productivity of secondary metabolites by culturing plant cells, such as anthraquinone, menthol and taxol, including guinealine, by adding cyclodextrin to plant cell culture medium. Is disclosed. In addition, there is a problem of safety and the failure to improve the extraction process of secondary metabolites by the demanding plant cell culture, there is a problem that does not improve the recovery rate of the final guinarin.
이에 본 발명자들은 생귀나린의 생산성 및 회수율을 모두 충족시키기 위하여 예의 노력한 결과, 생귀나린의 생산을 위한 식물세포의 배양에 있어 배양액에, 식물의 성장 및 생귀나린의 생산을 위한 배지의 조성을 달리하고 엘리씨터를 첨가함으로써 생귀나린의 생산성을 향상시킬 수 있으며, 상기 식물세포 배양액을 인체에 무해한 유기산 및 에탄올을 첨가하여 생귀나린 추출액을 만들고, 염을 첨가하여 추출함으로써 식물세포 배양액에 함유되어 있는 생귀나린을 효과적으로 분리 및 회수할 수 있음을 확인하고, 본 발명을 완성하게 되었다. Therefore, the present inventors have made intensive efforts to satisfy both the productivity and the recovery rate of fresh guinea pigs. As a result, in the culture of plant cells for the production of fresh guinea pigs, the composition of the medium for plant growth and the production of fresh guinarin and The productivity of raw guinealine can be improved by adding a citrate, and the guinealine contained in the plant cell culture medium is prepared by adding organic acid and ethanol which are harmless to the human body to make the raw guinea extract, and extracting with added salt. It was confirmed that the can be effectively separated and recovered, to complete the present invention.
결국, 본 발명의 목적은 생귀나린의 안전성, 생산성 및 회수율을 모두 향상시킬 수 있는 양귀비과 식물의 조직 배양에 의한 생귀나린의 제조 방법을 제공하는데 있다.After all, it is an object of the present invention to provide a method for producing fresh guinarin by tissue culture of poppy plants, which can improve both safety, productivity and recovery rate of fresh guinarine.
상기 목적을 달성하기 위하여, 본 발명은 양귀비과 식물의 캘러스를 현탁배양하여 생귀나린을 고농도로 생산한 다음, 다음의 단계를 거쳐 생귀나린을 회수하는 단계:In order to achieve the above object, the present invention is a suspension culture of the callus of the poppy family to produce a high concentration of raw guirin, and recovering the raw guirin through the following steps:
(a) 상기 식물세포 배양액을 건조한 후, 구연산(citric acid), 아세트산 또는 락틱산으로 구성된 그룹으로부터 선택된 1종 이상의 산(acid)과 제1의 유기용매를 이용하여 생귀나린 추출액을 만드는 단계; (b) 상기 생귀나린 추출액에 제2의 유기용매를 첨가하여 액/액 추출하고 수층을 분리하는 단계; (c) 상기 분리된 수층의 pH를 10 이상으로 조정한 다음, 제3의 유기용매를 첨가하여 액/액 추출하고 수층을 분리하는 단계; 및 (d) 상기 분리된 수층에 구연산(citric acid), 아세트산 또는 락틱산으로 구성된 그룹으로부터 선택된 1종 이상의 산(acid)이 포함된 증류수를 첨가하여 액/액 추출한 다음, 염을 첨가하여 침전물을 생성시키는 단계를 포함하는 것을 특징으로 하는 생귀나린의 제조방법을 제공한다.(a) drying the plant cell culture solution, and then preparing a fresh extract using a first organic solvent and at least one acid selected from the group consisting of citric acid, acetic acid or lactic acid; (b) extracting the liquid / liquid and separating the aqueous layer by adding a second organic solvent to the fresh extract; (c) adjusting the pH of the separated aqueous layer to 10 or more, followed by adding a third organic solvent to extract liquid / liquid and separating the aqueous layer; And (d) distilled water containing at least one acid selected from the group consisting of citric acid, acetic acid, or lactic acid to the separated aqueous layer, extracts liquid / liquid, and then adds a salt to precipitate the precipitate. It provides a method for producing guinarine characterized in that it comprises the step of producing.
본 발명에 있어서, 상기 양귀비과 식물은 박락희, 생귀나리아 케나덴시스 린네(Sanguinaria Canadensis Linne), 백굴채, 애기똥풀 또는 금영화(Eschscholtzia california)인 것을 특징으로 할 수 있으며, 바람직하게는 금영화인 것을 특징으로 할 수 있다.In the present invention, the poppy family may be characterized in that the Park Rak Hee, Sanguinaria Canadensis Linne ( Sanguinaria Canadensis Linne), baekryechae, celandine or Eschscholtzia california , preferably a gold film You can do
본 발명에 있어서, 상기 현탁배양시, 보트리티스 시네레아, 효모 추출물, 파이토프토라 메가스퍼마, 키틴, 키토산 및 글루칸으로 구성된 그룹으로부터 선택된 1종 이상의 엘리씨터를 첨가하는 것을 특징으로 할 수 있으며, 바람직하게는 보트 리티스 시네레아, 효모 추출물인 것을 특징으로 할 수 있다. In the present invention, in the suspension culture, at least one elite selected from the group consisting of Botrytis cinerea, yeast extract, phytophthora megasperma, chitin, chitosan and glucan can be added. And, it may be characterized in that the Botrytis cinerea, yeast extract.
본 발명에 있어서, 상기 제1의 유기용매는 에탄올인 것을 특징으로 할 수 있고, 상기 염은 황산마그네슘, 질산칼륨, 염화칼슘, 염화나트륨, 황산구리 또는 염화알루미늄인 것을 특징으로 할 수 있으며, 바람직하게는 염화나트륨인 것을 특징으로 할 수 있고, 상기 염은 생귀나린 추출액 100㎖에 대하여 10~15g으로 첨가하는 것을 특징으로 할 수 있다.In the present invention, the first organic solvent may be characterized in that the ethanol, the salt may be characterized in that the magnesium sulfate, potassium nitrate, calcium chloride, sodium chloride, copper sulfate or aluminum chloride, preferably sodium chloride It may be characterized in that, the salt may be characterized in that it is added in 10 ~ 15g with respect to 100ml of fresh guinea extract.
본 발명에 있어서, 상기 제2의 유기용매는 헥산인 것을, 제3의 유기용매는 메틸렌클로라이드(methylene chloride)인 것을 특징으로 할 수 있으며, 상기 액/액 추출은 3~5회 반복하여 수행하는 것을 특징으로 할 수 있다.In the present invention, the second organic solvent may be hexane, the third organic solvent may be characterized in that the methylene chloride (methylene chloride), the liquid / liquid extraction is performed repeatedly 3 to 5 times It may be characterized by.
본 발명에 있어서, 상기 생귀나린 회수 단계는 (d) 단계에서 생성된 침전물을 원심분리한 다음, 메탄올로 세척하고 건조시키는 단계를 추가로 포함하는 것을 특징으로 할 수 있다.In the present invention, the step of recovering the raw fish may further comprise the step of centrifuging the precipitate produced in step (d), followed by washing with methanol and drying.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
일반적으로 양귀비과 식물의 세포 배양시 생성되는 생귀나린을 비롯한 알칼로이드계 화합물은 유효한 생리적 또는 약리적 활성을 나타내지만, 세포내에 축적되거나 세포외로 배출되는 농도가 매우 낮을 뿐만 아니라, 분해되거나 다른 대사물로 전환되어 회수량이 매우 적다. 이에 본 발명은 양귀비과 식물의 세포 배양시 생귀나린의 생산성을 현저히 증가시키는 동시에, 안전성 및 회수율을 향상시킬 수 있는 생귀나린의 제조방법을 제공한다.In general, alkaloid-based compounds, such as guinarine, produced during the cell culture of poppy plants exhibit effective physiological or pharmacological activity, but not only have a very low concentration of intracellular or extracellular discharge, but also degrade or be converted into other metabolites. Very low recovery. Accordingly, the present invention provides a method for producing fresh guinarin, which can significantly increase productivity and improve safety and recovery rate of poppy guinealine in cell culture of poppy plants.
양귀비과 식물 중 금영화의 줄기를 선택하여, 0.5~2㎝ 정도로 절편화한 다음 2,4-D(2,4-dichlorophenoxy acetic acid), NAA(napthaleme acetic acid) 각각을 0.1~10.0㎎/ℓ의 양으로, 바람직하게는 0.1~5.0㎎/ℓ의 양으로 첨가한 MS 배지에 접종하여 캘러스를 유도한 후, 상기 유도된 캘러스를 NAA가 0.1~5.0㎎/ℓ의 양으로, 바람직하게는 2.0㎎/ℓ의 양으로 첨가된 MS 배지에서 증식을 유도한다. 이때, 배지의 pH가 5.5~6.0, 배양온도가 18~24℃인 조건에서 캘러스를 최대로 증식시킬 수 있다. 또한, 캘러스 증식에 영향을 미치는 생장조절제로 NAA, IBA, 2,4-D 각각을 0.1~2.0㎎/ℓ로 첨가하는 경우 더욱 바람직한 결과를 얻을 수 있다.Among the poppy family, the stem of the gold film was selected and sectioned about 0.5 ~ 2cm, and 2,4-D (2,4-dichlorophenoxy acetic acid) and NAA (napthaleme acetic acid) were each 0.1 ~ 10.0mg / ℓ. Induced callus by inoculating MS medium added in an amount of preferably 0.1-5.0 mg / L, and then inducing the callus in an amount of 0.1-5.0 mg / L NAA, preferably 2.0 mg. Proliferation is induced in MS medium added in an amount of / l. At this time, the pH of the medium can be propagated to the maximum callus under the conditions of 5.5 to 6.0, the culture temperature is 18 to 24 ℃. In addition, when the growth regulator affects callus proliferation, each of NAA, IBA, and 2,4-D is added at 0.1 to 2.0 mg / l.
캘러스 증식을 위해 사용되는 배지로서 MS(murashige-skoog) 배지 외에 SH(schenk-hildebrandt) 배지, B5(gamborg) 배지, White 배지 등을 사용할 수 있으며, SH, B5 및 White 배지를 사용하여 배양하였을 경우 효과는 거의 비슷하였으나, MS 배지에서 가장 바람직한 결과를 얻을 수 있다. In addition to MS (murashige-skoog) medium, in addition to MS (murashige-skoog) medium, SH (schenk-hildebrandt) medium, B5 (gamborg) medium, white medium, and the like can be used. Although the effects are almost the same, the most desirable results can be obtained in MS medium.
상기 증식된 캘러스 조직을 현탁 배양한 후, 식물의 성장을 위해 사용하였던 배지와 생귀나린의 생산을 위한 배지의 조성을 바꾸어 배양함으로써 생귀나린의 생산성을 향상시킬 수 있으며, 바람직하게는 식물 생장조절제로 NAA가 4.0~6.0㎎/ℓ의 양으로 첨가된 SH 배지에서 생귀나린의 생산성을 월등히 향상시킬 수 있다. 또한, 생귀나린의 생산성을 더욱 향상시키기 위하여, 생귀나린의 생합성 경로를 자극할 수 있는 엘리씨터(elicitor)를 첨가할 수 있다. 본 발명에서는 보트리티스 시네레아(Botrytis cinerea), 효모추출물(yeast extract), 파이토프토라 메가스퍼마, 키틴, 키토산 또는 글루칸 등의 엘리씨터를 첨가함으로써 생귀나린의 생산량을 급 격히 증가시킬 수 있다.After the suspension culture of the proliferated callus tissue, by changing the composition of the medium used for the growth of the plant and the production of raw guinarin culture can be improved productivity of the raw guinarin, preferably NAA as a plant growth regulator In the SH medium added in the amount of 4.0 to 6.0 mg / L can greatly improve the productivity of raw guinarin. In addition, in order to further improve the productivity of raw guinarin, an elicitor may be added that can stimulate the biosynthetic pathway of raw guinarin. In the present invention, by adding an elite element such as Botrytis cinerea , yeast extract, yeast extract, phytophthora megasperma, chitin, chitosan or glucan, the production amount of guinea pigs can be drastically increased. have.
상기와 같이 수득된 식물세포 배양액에는 생귀나린 이외에, 첼러리스린(chelerythrine), 생귀루틴(sanguilutine), 생귀루빈(sanguirubine), 첼리루틴(chelilutine) 등의 알칼로이드 유도체가 존재한다. 본 발명에서는, 상기 세포 배양액을 구연산, 아세트산 또는 락틱산의 유기산 및 제1의 유기용매로 추출한 후 이를, 제2의 유기용매, 및 제3의 유기용매로 수층을 분리하여, 구연산이 포함된 증류수로 재추출한 다음, 염을 처리함으로써 다수의 알칼로이드계 화합물 중에서 생귀나린만을 효과적으로 분리 및 회수할 수 있다. In the plant cell culture obtained as above, alkaloid derivatives such as chelerythrine, sanguilutine, sanguirubine, and chelilutine are present in addition to chlorinthrine. In the present invention, the cell culture solution is extracted with an organic acid of citric acid, acetic acid or lactic acid and a first organic solvent, and then separated from the aqueous layer by a second organic solvent and a third organic solvent, distilled water containing citric acid After re-extracting, the salts can be treated to effectively separate and recover only raw Guinarin from a large number of alkaloid compounds.
본 발명에서는 기존의 생귀나린 추출시 통상 사용되던 인체에 유해한, 염산(HCl) 및 메탄올 대신 인체에 보다 안전한 구연산, 락틱산, 아세트산과 같은 유기산과 에탄올을 사용함으로써 안전성을 높일 수 있다. In the present invention, by using organic acids and ethanol, such as citric acid, lactic acid, acetic acid, which is safer for the human body, instead of hydrochloric acid (HCl) and methanol, which are harmful to the human body, which is conventionally used in the extraction of conventional raw fish, can increase safety.
또한, 본 발명에서 염을 처리한 후, 배양액을 단지 방치함으로써도 침전물을 얻을 수 있으나, 회수를 쉽게 하기 위하여 원심 분리하는 것이 바람직하며, 사용되는 염의 종류는 특별히 한정되지 않으나, 바람직하게는 황산마그네슘, 질산칼륨, 염화칼슘, 염화나트륨, 황산구리, 염화알루미늄을, 더욱 바람직하게는 염화나트륨을 사용할 수 있다.In addition, after the salt is treated in the present invention, a precipitate can be obtained even by leaving the culture solution alone, but it is preferable to centrifuge for easy recovery, and the type of salt used is not particularly limited, but preferably magnesium sulfate , Potassium nitrate, calcium chloride, sodium chloride, copper sulfate, aluminum chloride, more preferably sodium chloride.
본 발명에서 상기 세포 배양액은 세포를 포함하는 세포 배양액 또는 세포를 제거한 배양여액을 포함한다.In the present invention, the cell culture solution includes a cell culture solution containing cells or a culture filtrate from which cells are removed.
또한, 본 발명에서는 생귀나린을 구연산과 같은 인체에 해가 없는 산이 포함된 증류수로 추출함으로써 독성 및 부작용의 문제가 없다.In addition, in the present invention, by extracting the raw guinarin with distilled water containing acid, which is harmless to the human body, such as citric acid, there is no problem of toxicity and side effects.
상기 본 발명에서는 양귀비과 식물 중 금영화만을 예로 들어 설명하였으나, 본 발명은 박락희, 생귀나리아 케나덴시스 린네(Sanguinaria Canadensis Linne), 백굴채 및 애기똥풀 등 생귀나린을 함유하고 있는 모든 식물종에 적용가능하며, 이에 의해 제한되지 않는다.Although the present invention has been described using only the gold film of the poppy family as an example, the present invention can be applied to all plant species containing raw guirin, such as Park, Lak-hee, Sanguinaria Canadensis Linne, white oyster and celandine. It is not limited thereto.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention, it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as being limited by these examples.
실시예 1Example 1 : 생귀나린 생산의 최적 조건 선정: Selection of Optimum Condition for Raw Fish Production
1-1. 캘러스 유도 및 증식1-1. Callus Induction and Proliferation
양귀비과 식물의 일종인 금영화의 줄기를 채취하여 멸균소독한 후, 0.5~2㎝정도의 절편으로 한 다음 2,4-D(2,4-dichlorophenoxy acetic acid) 0.1㎎/ℓ, NAA 2.0㎎/ℓ을 첨가한 MS(murashige-skoog) 배지에 접종하고, 23℃, 암상태로 유지되는 배양실에 옮겨 캘러스를 유도하였다. After sterilizing and disinfecting the stem of gold film, a kind of poppy family, it is cut into 0.5 ~ 2cm sections, and then 2,4-D (2,4-dichlorophenoxy acetic acid) 0.1mg / ℓ, NAA 2.0mg / L was added to murashige-skoog (MS) medium and transferred to a culture chamber maintained at 23 ° C. in the dark to induce callus.
상기와 같이 유도된 캘러스를 최단기간 내에 최대 증식되도록 하는 조건을 선정하기 위하여 하기와 같이 실험하였다. 즉, NAA 2.0㎎/ℓ가 첨가된 MS 배지 30㎖를 일회용 페트리쉬 접시에 분주한 후, 상기 실시예 1-1에서 얻은 금영화의 캘러스를 절편화하여 접종하였다. 배지의 pH를 4.0, 5.0, 5.5, 6.0, 6.5, 7.0로 각각 구분하고, 배양온도를 15℃, 17℃, 19℃, 21℃, 23℃, 25℃로 구분하여 캘러스 증식을 관찰하였다.In order to select the conditions for the maximum growth in the callus induced as described above in the shortest period, the experiment was as follows. That is, 30 ml of MS medium to which NAA 2.0 mg / l was added was dispensed into a disposable Petri dish, and then the callus of the gold film obtained in Example 1-1 was sectioned and inoculated. The pH of the medium was divided into 4.0, 5.0, 5.5, 6.0, 6.5, and 7.0, and the callus growth was observed by dividing the culture temperature into 15 ° C, 17 ° C, 19 ° C, 21 ° C, 23 ° C, and 25 ° C.
그 결과, 배지 pH 5.5~6.0, 배양온도 18~24℃의 범위가 캘러스 증식의 최적 조건인 것을 확인할 수 있었다.As a result, it was confirmed that the range of the medium pH 5.5 to 6.0 and the culture temperature of 18 to 24 ° C was the optimal condition for callus growth.
1-2. 생장조절제 첨가가 캘러스 증식에 미치는 영향1-2. Effect of Growth Regulators on Callus Growth
상기 실시예 1-1에서 얻은 금영화의 캘러스를 pH 6.0으로 고정시키고, 생장조절제로 NAA, IBA, 2,4-D 각각을 각각 0.1㎎/ℓ, 1.0㎎/ℓ, 2.0㎎/ℓ, 3.0㎎/ℓ, 5.0㎎/ℓ씩 첨가한 MS 배지에 치상하여 생장조절제 첨가가 캘러스 증식에 미치는 영향을 알아보았다. 치상 후 2주 간격으로 같은 조성의 새로운 배지에 옮겼으며, 10주 후 캘러스의 증식정도와 상태를 관찰하였다.The callus of the gold film obtained in Example 1-1 was fixed at pH 6.0, and each of NAA, IBA, 2,4-D was 0.1 mg / L, 1.0 mg / L, 2.0 mg / L, 3.0 as a growth regulator. The effect of growth regulators on callus proliferation was examined by placing the MG / L and 5.0 mg / L into MS medium. After dental treatment, the cells were transferred to fresh medium of the same composition every two weeks, and after 10 weeks, the extent and condition of callus were observed.
그 결과, 하기 표 1에 나타낸 바와 같이, 생장조절제를 처리하지 않은 배지보다 생장조절제를 처리한 배지에서 우수한 생체중 증가를 보였으며, 또한, IBA 및 NAA가 첨가된 배지에서는 4배 이상의 생체중 증가를 보였고, 적정농도는 1.0~2.0㎎/ℓ인 것을 확인할 수 있었다. 한편, 2,4-D를 첨가한 경우에는 생체중이 현저히 증가하였으며, 적정농도는 0.1~1.0㎎/ℓ인 것을 알 수 있었다.As a result, as shown in Table 1, the growth in the growth-treated medium was superior to the medium without the growth regulator, and also in the medium added IBA and NAA showed a more than four-fold increase in live weight , The titration concentration was confirmed to be 1.0 ~ 2.0mg / ℓ. On the other hand, the addition of 2,4-D significantly increased the body weight, it can be seen that the optimum concentration is 0.1 ~ 1.0mg / ℓ.
1-3. 배지의 조성 변화가 생귀나린 생산성에 미치는 영향1-3. Effect of Medium Composition on Unprecedented Productivity
상기 1-2의 최적조건에서 증식된 캘러스를 2,4-D 1.0㎎/ℓ가 첨가된 액체 배지로 옮겨 액체 현탁배양을 유도하였다. 액체 배지 50㎖를 함유한 300㎖ 삼각 플라스크에 약 1.0g의 잘자란 캘러스를 유도하고, 암상태, 온도 23℃로 조절되는 회전 진탕기에서 120rpm의 속도로 진탕하여 액체 배양한 후 7일 간격으로 계대하였다. Callus grown at the optimum condition of 1-2 was transferred to a liquid medium to which 2,4-D 1.0 mg / L was added to induce liquid suspension culture. A 300 ml Erlenmeyer flask containing 50 ml of liquid medium was induced and about 1.0 g of fine callus was shaken at a speed of 120 rpm in a rotary shaker controlled at 23 ° C. in a dark state, followed by culturing of liquid at 7 days intervals. Passed.
배지의 조성 변화에 따른 생귀나린의 생산성을 알아보기 위하여, 상기 액체 현탁배양유지 배지에서 3주간 배양시킨 다음, 잘자란 세포만을 모아 식물 생장조절제로 NAA를 0~12㎎/ℓ의 농도로 단계별로 첨가한 SH 배지에서 2주간 더 배양하여 생귀나린의 생산성을 비교하였다.In order to determine the productivity of fresh guinarin according to the change of the composition of the medium, incubated for 3 weeks in the liquid suspension culture medium, and then collected only well-grown cells step by step NAA at a concentration of 0 ~ 12mg / ℓ as a plant growth regulator Incubate for 2 more weeks in the added SH medium to compare the productivity of raw guinarin.
생귀나린을 정량하기 위하여, 상기 식물세포 현탁 배양액을 와트만 여과지로 여과한 후, 무게를 측정하고 오븐에서 건조시켜 건조량을 측정한 다음, 세포내 함유량의 측정을 위해 세포를 20분 동안 실온에서 초음파로 파괴하여 추출하였다. 또한, 여액내 함유량을 측정하기 위하여 헥산을 사용하여 추출하였다. 상기 세포 및 추출액에서의 생귀나린의 함량을 정량하기 위하여 HPLC를 수행하였다. 이때, HPLC는 수펠코실(supelcosil)-18-DB컬럼(직경 4.6㎜× 15㎝)으로, 아세토니트릴과 물(35:65)의 혼합용매를 용출용매로 사용하여 공지의 분석방법에 따라 수행하였다.To quantify the vitreous rinse, the plant cell suspension culture was filtered with Whatman filter paper, weighed and dried in an oven to measure the amount of drying, and the cells were sonicated for 20 minutes at room temperature for measurement of intracellular content. Extracted by breaking with. In addition, extraction was performed using hexane to measure the content in the filtrate. HPLC was performed to quantify the content of virinin in the cells and extracts. At this time, HPLC was carried out according to a known analytical method using a mixed solution of acetonitrile and water (35:65) as a supelcosil-18-DB column (diameter 4.6 mm × 15 cm). .
그 결과, 하기 표 2에 나타낸 바와 같이, 현탁배양 후 배지의 조성을 바꾸어 주었을 경우 생귀나린의 생산량이 증가하였으며, 또한, NAA를 4.0~6.0㎎/ℓ의 농도로 첨가하였을 경우에 생귀나린의 생산성이 현저히 증가하는 것을 확인할 수 있었다.As a result, as shown in Table 2, when the composition of the medium was changed after suspension culture, the production of raw guinarin increased, and when the NAA was added at a concentration of 4.0 to 6.0 mg / L, It was confirmed that the increase significantly.
1-4. 엘리씨터 첨가가 생귀나린 생산성에 미치는 영향1-4. Effect of Eliator on Unprecedented Productivity
알칼로이드의 생산성을 향상시키기 위하여 생합성 경로를 자극하는 방법이 이용되고 있는데, 본 발명에서도 여러 가지 엘리씨터를 처리한 후, 엘리씨터의 처리가 생귀나린의 생산성에 미치는 영향을 알아보았다. 일반적으로 생합성 경로의 자극은 보통 중금속류 등과 같은 무생물 기원의 물질들과 곰팡이 세포벽 성분과 같은 생물 유래의 물질들이 사용될 수 있다. In order to improve the productivity of alkaloids, a method of stimulating a biosynthetic pathway is used. In the present invention, after treating various eliminators, the effect of the treatment of the eliminator on the productivity of the raw guinarin was examined. In general, the stimulation of the biosynthetic pathway can be used for non-living materials such as heavy metals and biological materials such as fungal cell wall components.
상기 실시예 1-3의 배지내로 보트리티스 시네레아와 효모추출물의 엘리씨터를 첨가한 후, 엘리씨터 첨가에 따른 생귀나린의 생산성 향상을 측정하였다. After the addition of the eliminator of the botrytis cinerea and yeast extract into the medium of Examples 1-3, the productivity improvement of the guinearin by the addition of the elite was measured.
1-4-1 엘리시터로 보트리티스 시네레아를 사용한 경우1-4-1 When Botrytis Cinerea is used as an eliminator
엘리씨터로 보트리티스 시네레아를 사용하였다. 도 1의 (가)는 보트리티스 시네레아를 엘리시터로 사용한 경우 생귀나린 및 다이하이드로 생귀나린의 생산 증가량을 엘리시터를 첨가하지 않은 대조구(control)와 비교하여 나타낸 그래프이다. 그래프를 살펴보면, 보트리티스 시네레아를 첨가한 경우 생귀나린 및 다이하이드로 생귀나린의 생산량은 3배 이상 증가하는 것을 알 수 있다. Botrytis Cinerea was used as the elementator. Figure 1 (a) is a graph showing the increase in production of raw guinarin and dihydro raw guinarin when the Botrytis cinerea is used as an eliminator compared to the control without the addition of the eliminator. Looking at the graph, it can be seen that the production of fresh guinarin and dihydro fresh guinarin increased more than three times with the addition of Botrytis cinerea.
1-4-2 엘리시터로 효모 추출물을 사용한 경우1-4-2 Using Yeast Extract as Eliminator
엘리씨터로 효모 추출물을 사용하였다. 도 1의 (나)는 효모 추출물을 엘리시터로 사용한 경우 생귀나린 및 다이하이드로 생귀나린의 생산 증가량을 그리고 (다)는 효모 추출물을 정제하여 사용할 경우 생귀나린 및 다이하이드로 생귀나린의 생산량 증가량을 엘리시터를 첨가하지 않은 대조구(control)와 비교한 것이다. 그래프를 살펴보면, 효모추출물을 첨가한 경우 생귀나린 및 다이하이드로 생귀나린의 생산량은 6배 내지 10배 정도 증가하는 것을 알 수 있다. Yeast extract was used as an eliminator. Figure 1 (b) is an increase in the production of raw guinealine and dihydro guinealine when the yeast extract is used as an eliminator and (c) is an increase in the production of raw guinealine and dihydro guinealine when the yeast extract is purified It is compared with a control without adding a sheeter. Looking at the graph, it can be seen that when yeast extract is added, the production of raw guinarin and dihydro virgin guinarin is increased by 6 to 10 times.
그 밖에 상기 실시예 1-3의 배지내로 여러 가지의 엘리씨터를 첨가한 후, 엘리씨터 첨가에 따른 생귀나린의 생산성 향상을 측정하였다. 엘리씨터로 파이토프토라 메가스퍼마의 세포벽 추출물은 공지의 방법에 따라 1주 동안 1.5ℓ의 액체 정치 배양된 세포로부터 약 80㎎의 세포벽 성분을 추출하여 사용하였으며, 키틴, 키토산, 글루칸, 벤조산, 셀루라아제, 메틸 자스몬(methyl jasmone), 시스 자스몬(cis jasmone), 에틸렌(ethylene)은 시그마사로부터 구입하여 사용하였다. In addition, after the addition of various kinds of elite in the medium of Example 1-3, the productivity improvement of the raw guinarin according to the addition of the elite was measured. Cell wall extract of phytophthora megasperma was used by extracting about 80 mg of cell wall components from 1.5 L liquid cultured cells for 1 week according to a known method. Chitin, chitosan, glucan and benzoic acid were used. , Cellulase, methyl jasmone (methyl jasmone), cis jasmone (cis jasmone), ethylene (ethylene) was purchased from Sigma used.
상기의 결과를 하기 표 3에 나타내었다. 보트리티스 시네레아, 효모 추출물의 경우에는 현저하게 생귀나린의 생산량이 증가하였고, 파이토프토라 메가스퍼마, 키틴, 키토산, 글루칸을 첨가하였을 경우에는 약 1.5~2.5배 정도 생귀나린의 생산량이 증가하였다. 반대로, 셀루라아제, 시스 자스몬을 첨가하였을 경우에는 오히려 생귀나린의 생산량이 감소하였다. The results are shown in Table 3 below. In the case of Botrytis cinerea and yeast extract, the production of raw guinarin was significantly increased, and the production of fresh guinarin increased about 1.5 to 2.5 times with the addition of phytophthora megasperma, chitin, chitosan, and glucan. It was. Conversely, the addition of cellulase and cis jasmon decreased the production of guinarin rather.
실시예 2:Example 2: 생귀나린 회수의 최적 조건 선정 Selection of Optimum Condition for Raw Fish Collection
2-1. 유기산과 에탄올을 이용한 생귀나린 추출2-1. Raw Extracts Using Organic Acids and Ethanol
식물세포 배양이 끝난 세포 배양액에는 생귀나린뿐만 아니라, 생귀루틴, 생귀루빈, 첼레리스린, 첼리루틴 등의 알칼로이드 유도체가 존재하므로, 생귀나린만을 효과적으로 분리 및 회수하기 위한 추출조건을 선정하기 위하여 하기와 같이 실험하였다. In addition to raw guirin, alkaloid derivatives such as fresh guirin, fresh guirubin, celeryrin, and cellirutin are present in the cell culture medium after plant cell culture. Therefore, in order to select extraction conditions for effectively separating and recovering only raw guirin, Experimented together.
실시예 1의 방법으로 2주간 배양한 셀을 건조한 후 2g을 취하여 아세트산(acetic acid), 락트산(lactic acid), 구연산(citric acid)이 첨가된 pH 2, 3의 추출용매 10ml와 에탄올을 넣고 초음파 분쇄(sonication)를 50℃에서 60분 실시하고, 볼텍싱(vortexing)을 20분간 실시한 후 원심분리하여 상등액만 분리하는 작업을 2회 반복하였다. 이를 0.45μm 멤브레인 필터(membrane filter)에 통과 시킨 후 HPLC로 분석하였다. After drying the cells incubated for 2 weeks using the method of Example 1, 2 g of the extract was added with 10 ml of an extraction solvent of
분석한 결과는 도 2와 같이 락트산(pH 2)를 첨가하여 추출하였을때 생귀나린이 1598ppm, 첼레리스린이 7179ppm, 다이하이드로 생귀나린이 4638ppm으로 가장 추출효율이 높았다. As a result of the analysis, when extracted with lactic acid (pH 2) as shown in Fig. 2, the extraction efficiency was high as 1598 ppm of guinealine, 7179 ppm of celeryrin, and 4638 ppm of dihydro guinarine.
2-2. 생귀나린의 회수2-2. Recovery of Raw Guina
상기 실시예 2-1에서 얻은 세포 현탁 배양액을 거름종이로 거른 다음, 동량의 헥산을 가하여 추출하였다. 이 과정을 3회 반복한 후 수득된 수층에 1N NaOH 수용액을 가하여 pH를 10으로 조정한 다음 동량의 메틸렌클로라이드를 이용하여 재추출한 후, 구연산이 포함된 동량의 증류수(pH 2.30, citric acid 3~5g/100㎖)를 가하여 다시 한번 추출하였다. The cell suspension culture obtained in Example 2-1 was filtered with a filter paper, and extracted with the same amount of hexane. After repeating this process three times, 1N NaOH aqueous solution was added to the obtained aqueous layer to adjust the pH to 10, and then re-extracted using the same amount of methylene chloride, followed by the same amount of distilled water containing citric acid (pH 2.30, citric acid 3 ~). 5 g / 100 ml) was added and extracted again.
2-3. 염의 첨가에 따른 생귀나린의 회수 효과2-3. Recovery Effect of Raw Guinea with Addition of Salt
상기와 같은 방법으로 수득된 추출액 100㎖당 10~15g의 염화나트륨(NaCl) 염을 첨가하여 교반한 다음 원심분리하였다. 원심분리 후 상등액과 침전물을 분리한 다음 각각에 증류수를 첨가하여 상기 실시예 1-3에 기재된 조건으로 HPLC를 수행하여 생귀나린의 회수율을 비교하였다.10 to 15 g of sodium chloride (NaCl) salt was added per 100 ml of the extract obtained in the same manner, followed by stirring, followed by centrifugation. After centrifugation, the supernatant and the precipitate were separated, and distilled water was added thereto, respectively, and HPLC was performed under the conditions described in Examples 1-3, to compare the recovery of guinea saline.
그 결과, 하기 표 4에 나타낸 바와 같이, 추출공정에 염화나트륨 염을 첨가한 경우, 첨가하지 않은 경우에 비하여 생귀나린의 회수율이 월등히 향상되는 것을 확인할 수 있었다.As a result, as shown in Table 4 below, when sodium chloride salt was added to the extraction step, it was confirmed that the recovery rate of raw Guinarin was significantly improved as compared with the case without addition.
2-4. 첨가염의 종류에 따른 생귀나린의 회수 효과2-4. Recovery Effect of Fresh Guinarin by Addition Salts
첨가되는 염의 종류를 달리하여, 상기 실시예 2-2와 동일하게 추출공정을 수행하여, 첨가염의 종류에 따른 생귀나린의 회수 효과를 알아보았다. 즉, 1M 농도의 황산마그네슘, 질산칼륨, 염화칼슘, 염화나트륨, 황산구리, 염화알루미늄을 각각 첨가하여 잘 섞은 후, 원심분리한 다음 상등액 및 침전물을 분리하여 각각에 증류수를 첨가하고, 상기 실시예 1-3에 기재된 조건으로 HPLC를 수행하여 생귀나린의 회수율을 측정하였다.By varying the type of salt added, the extraction process was performed in the same manner as in Example 2-2, to determine the recovery effect of raw guinarin according to the type of added salt. That is, magnesium sulfate, potassium nitrate, calcium chloride, sodium chloride, copper sulfate, and aluminum chloride at a concentration of 1 M are added and mixed well, followed by centrifugation, and a supernatant and a precipitate are separated, and distilled water is added thereto, respectively. HPLC was carried out under the conditions described in to determine the recovery of guinarine.
그 결과, 염화나트륨 염을 첨가한 경우 가장 좋은 회수율을 나타내는 것을 알 수 있었다. 이에 따라 식물세포 배양액에 염을 첨가하여, 특히 염화나트륨 염을 첨가하여 추출할 경우 더욱 효과적으로 생귀나린을 분리 및 회수할 수 있는 것을 확인할 수 있었다.As a result, it was found that the best recovery was obtained when sodium chloride salt was added. Accordingly, when the salt was added to the plant cell culture solution, and especially the sodium chloride salt was added, it was confirmed that the guinarine was more effectively separated and recovered.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.Having described the specific part of the present invention in detail, it is obvious to those skilled in the art that such a specific description is only a preferred embodiment, thereby not limiting the scope of the present invention. something to do. Thus, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
이상에서 상세히 설명한 바와 같이, 본 발명에 의하면 종래의 방법에 비하여 생귀나린의 생산성 및 회수율을 현격히 향상시킬 수 있고, 인체에 무해한 추출방법을 이용함으로서 안전성을 높힐 수 있으며, 항균물질로 광범위한 분야에서 사용되고 있는 생귀나린의 대량 생산을 가능하게 하여, 이를 이용한 화장품, 식품 첨가제 및 의료용 제제의 생산원가를 절감시키는 효과가 있다. As described in detail above, according to the present invention, the productivity and recovery rate of raw guinarin can be significantly improved compared to the conventional method, and the safety can be increased by using an extraction method that is harmless to the human body, and it is used in a wide range of fields as an antimicrobial material. By enabling the mass production of fresh guinarin, there is an effect of reducing the production cost of cosmetics, food additives and medical preparations using the same.
Claims (13)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020050012957A KR20060092308A (en) | 2005-02-17 | 2005-02-17 | Method for producing guinarine by tissue culture of poppy family |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020050012957A KR20060092308A (en) | 2005-02-17 | 2005-02-17 | Method for producing guinarine by tissue culture of poppy family |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20060092308A true KR20060092308A (en) | 2006-08-23 |
Family
ID=37593725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020050012957A Ceased KR20060092308A (en) | 2005-02-17 | 2005-02-17 | Method for producing guinarine by tissue culture of poppy family |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20060092308A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150062577A (en) * | 2013-11-29 | 2015-06-08 | (주)아모레퍼시픽 | A method of extracting natural ingredients of cucumber and cosmetic composition comprising the extracted ingredients |
| EP2063816B1 (en) | 2006-09-22 | 2015-08-12 | U & I Corporation | Implants comprising biodegradable metals and method for manufacturing the same |
-
2005
- 2005-02-17 KR KR1020050012957A patent/KR20060092308A/en not_active Ceased
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2063816B1 (en) | 2006-09-22 | 2015-08-12 | U & I Corporation | Implants comprising biodegradable metals and method for manufacturing the same |
| KR20150062577A (en) * | 2013-11-29 | 2015-06-08 | (주)아모레퍼시픽 | A method of extracting natural ingredients of cucumber and cosmetic composition comprising the extracted ingredients |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | Stimulation of taxol production and excretion in Taxus spp cell cultures by rare earth chemical lanthanum | |
| WO2020177390A1 (en) | Method for preparing l-ergothioneine-containing cosmetic stock solution by means of fermenting hericium erinaceus | |
| KR101313783B1 (en) | Composition for rice bacterial blight suppressing activity | |
| CN106613350A (en) | Schizophyllum commune and domestication and cultivation method and application thereof | |
| JP2009500013A (en) | Method for producing corosolic acid by plant cell suspension culture | |
| KR102140050B1 (en) | Production method of Lycoris radiata adventitious roots for producing galantamine | |
| CN112079692A (en) | Compound for preventing and treating plant pathogenic bacteria and application thereof | |
| JP2019508053A (en) | Method for mass production of biniferin using stevioside from cell culture of grapevine tissue | |
| AU2014358838B2 (en) | Production of thapsigargins by Thapsia cell suspension culture | |
| KR102025818B1 (en) | Natural antibacterial agent and manufacturing method thereof | |
| JP2009072132A (en) | Method for producing brown algae with high content of health functional ingredients | |
| KR20070104293A (en) | Mushroom cultivation medium and its manufacturing method | |
| KR20060092308A (en) | Method for producing guinarine by tissue culture of poppy family | |
| CN109602006B (en) | Culture purification method and application of active substance containing peony stem cells | |
| Abdoli et al. | Influence of KNO3, CaCl2 and MgSO4 concentrations on growth and cichoric acid accumulation in hairy root culture of purple coneflower (Echinacea purpurea L.) | |
| CN1184309C (en) | Method for producing tripterygium alkaloids by plant suspension cultivation cell | |
| KR102226151B1 (en) | Method for producing coumestrol using leguminous plants | |
| Gulyamova et al. | Effect of epigenetic modifiers on fermentation parameters of endophytic fungi from plants growing in Uzbekistan | |
| Mini et al. | Standardization of callus induction in Saraca indica Auct, Non Linn | |
| Mei et al. | Nitraria sibirica cell suspension culture: establishment, characterization and application | |
| Al-Qarni et al. | Anticandidal activity and chemicals of commiphora Gileadensis (l.) C. Chr.(burseraceae) growning in south Western region of saudi arabia | |
| KR0140787B1 (en) | Method for producing twinguirin and its derivatives by cell culture of plants of the genus Maccleya | |
| Keerthiga et al. | In vitro propagation of Wedelia trilobata (L.) using Phormidium subincrustatum extracts: A novel approach | |
| KR19990069221A (en) | Extract and Preparation Method of Tea Tree Species with Antimicrobial Activity | |
| JP2649164B2 (en) | Marigold tissue culture method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20050217 |
|
| PA0201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20060630 Patent event code: PE09021S01D |
|
| PG1501 | Laying open of application | ||
| E90F | Notification of reason for final refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20061215 Patent event code: PE09021S02D |
|
| E601 | Decision to refuse application | ||
| E801 | Decision on dismissal of amendment | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20070531 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20061215 Comment text: Final Notice of Reason for Refusal Patent event code: PE06011S02I Patent event date: 20060630 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| PE0801 | Dismissal of amendment |
Patent event code: PE08012E01D Comment text: Decision on Dismissal of Amendment Patent event date: 20070531 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20070213 Patent event code: PE08011R01I Comment text: Amendment to Specification, etc. Patent event date: 20060821 |